CaMutQC: An R package for integrative quality control and filtration of cancer somatic mutations
- PMID: 40727424
- PMCID: PMC12302822
- DOI: 10.1016/j.csbj.2025.07.011
CaMutQC: An R package for integrative quality control and filtration of cancer somatic mutations
Abstract
The quality control and filtration of cancer somatic mutations (CAMs), including the elimination of false positives due to technical bias and the selection of key mutation candidates, are crucial steps for downstream analysis in cancer genomics. However, due to diverse needs and the lack of standardized filtering criteria, the filtering strategies applied vary from study to study, often resulting in reduced efficiency, accuracy, and reproducibility. Here, we present CaMutQC, a heuristic quality control and soft-filtering R/Bioconductor package designed specifically for CAMs. CaMutQC enables users to remove false positive mutations, select potential mutation candidates, and estimate Tumor Mutation Burden (TMB) with a single line of code, using either default or customized parameters. A filter report and a code log can also be generated after the filtration process to facilitate reproducibility and comparison. The application of CaMutQC to a Whole-exome Sequencing (WES) benchmark dataset demonstrated its strong capability by eliminating 85.55 % of false positive Single nucleotide variants (SNVs) while retaining 90.72 % of true positive SNVs. Additionally, an additional 11.56 % of true positive SNVs were rescued through CaMutQC's built-in union strategy. Similar results were observed for Insertions and Deletions (INDELs). CaMutQC is freely available through Bioconductor at https://bioconductor.org/packages/CaMutQC/ under the GPL v3 license.
Keywords: CaMutQC; Cancer somatic mutation; False positive mutation; Mutation filtering; Quality control.
© 2025 The Authors.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
Figures





Similar articles
-
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2. Cochrane Database Syst Rev. 2022. PMID: 35233774 Free PMC article.
-
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
-
Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort.Commun Med (Lond). 2025 Jun 16;5(1):236. doi: 10.1038/s43856-025-00934-3. Commun Med (Lond). 2025. PMID: 40523952 Free PMC article.
-
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children.Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011196. doi: 10.1002/14651858.CD011196.pub2. Cochrane Database Syst Rev. 2025. PMID: 39968844
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
References
-
- Hedegaard J., Thorsen K., Lund M.K., Hein A.-M.K., Hamilton-Dutoit S.J., et al. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PloS One. 2014;9(5) doi: 10.1371/journal.pone.0098187. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources